Max Healthcare Institute Ltd

Know More

770.3533.60 (4.56%)

12:00 AM,2nd Mar 2024

768.0031.60 (4.29%)

12:00 AM,2nd Mar 2024

BSE : 543220


Sector : Health care

ISIN Code : INE027H01010

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Mar 02 2024 | 12:00 AM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)


Face Value


52-WK High


52-WK High Date

13 Feb 2024

52-WK Low


52-WK Low Date

06 Apr 2023

All Time High


All Time High Date

13 Feb 2024

All Time Low


All Time Low Date

12 Nov 2020

Max Healthcare Institute Ltd

Max Healthcare Institute Limited was originally incorporated as Infinitum Technologies Private Limited at New Delhi India as a Private Limited Company dated June 18 2001. Pursuant to a Fresh Certificate of Incorporation dated June 28 2002 the name of `Infinitum Technologies Private Limited' was changed to `Max Healthcare Institute Private Limited'. Thereafter pursuant to a Special Resolution dated May 16 2002 and a fresh Certificate of Incorporation dated October 18 2002 the Company converted to a Public Limited and name was changed to `Max Healthcare Institute Limited'. The Company is primarily engaged in provision of healthcare services through primary care clinics multi speciality hospitals / medical centres and superspeciality Hospitals facilities. The Company is a leading hospital chains in India with major concentration in North India consisting of a network of 13 network healthcare facilities which includes BLK Hospital and BNH Hospital. Besides it provides healthcare services across secondary and tertiary care specialties with key focus on centres of excellence i.e. oncology neurosciences cardiac sciences orthopaedicsrenal sciences liver and biliary sciences and minimal access metabolic and bariatric surgery (MAMBS).In addition to core hospital business the company has two SBUs namely MaxHome and MaxLab. MaxHome is a platform that provides health and wellness services at home. It has 12 service lines including pathology pharmacy delivery physiotherapy and critical care nursing. MaxLab offers pathology services to patients outside of hospitals through a variety of channels including third party hospital laboratory management. Eight hospitals and five medical centres are located in Delhi and the NCR and the others are located in cities of Mumbai Mohali Bathinda and Dehradun. They provide diagnostic pathology radiology radiation oncology and clinical services in select specialties/ departments through deployment of doctors and other medical staff in 4 Partner Healthcare Facilities.In addition it has established a representative office in Nairobi Kenya under the name `True Max Healthcare' which helps in partnering with local hospitals conducting OPDs assisting the potential patients with medical visas and pre - travel preparation and participating in local events to build its brand internationally. In the year 2000 the Company opened first Medcentre with out-patient facilities and day care surgeries at Max Medcentre Panchsheel Park.In the year 2002 there were facilities opened in Pitampura and Noida subject to hospital in Pitampura became the first ISO certified hospital for high-end secondary care.In 2004 the Company opened its first super tertiary care facility with advanced cardiac life support ambulances and air evacuation service at Max Heart & Vascular Institute Saket. In 2005 multi-speciality tertiary care centre in East Delhi with 147 beds three operation theatres and 1 cardiac catheterization laboratory at Max Hospital Patparganj were opened by the Company. In 2006 there was opening of first super speciality tertiary care location at Max Super Speciality Hospital Saket.The Company received NABH and NABL certification for laboratories and simultaneously opened a high-end secondary care hospital at Gurgaon in the year of 2007.The BLK Hospital was redeveloped and re-launched as a multi super speciality facility by the Company in 2009.On 05 August 2009 through a concession agreement the Company entered into a public private partnership (PPP) with the Department of Health and Family Welfare (DHFW) Government of Punjab and HBPL (Hometrail Buildtech Private Limited) the Company's subsidiary merged with HEPL (Hometrail Estate Private Limited) for development of greenfield super speciality hospital in Bathinda Punjab which was engaged in the development of greenfield super speciality hospital in Mohali Punjab.In 2010 the BLK Hospital received NABH accreditation and therby the Company opened a 300 bedded hospital in Shalimar Bagh. In 2011 the Company thru HBPL extended its footprint in North India through a public private partnership with State Government of Punjab with setting up of hospitals in Mohali and Bathinda. In 2012 the first super speciality hospital in Uttarakhand Max Super Speciality Hospital Dehradun was opened and the Company's BLK Hospital installed Asia Pacific regions' first cyber-knife VSI - an ultra modern latest generation PET-CT to aid accurate diagnosis.In 2013 the BLK Hospital commenced liver and kidney transplant services. Max Healthcare successfully performed 100 bone marrow transplant surgeries within a span of 24 months and landmark surgery on separating two conjoint Nigerian twins respectively. On 28 May 2015 the Company acquired controlling stake in Crosslay Remedies Limited (CRL) a subsidiary that owns and operates a 378 bedded hospital with 328 operational beds located in East Delhi-Ghaziabad-Noida corridor. The Company further had acquired 51% stake in Saket City Hospitals Private Limited a subsidiary of the Company (SCHPL) pursuant to which it became a subsidiary in 2015.In 2016 the company launched its vertical Max@Home Max Lab and India's first oncology day-care center at Lajpat Nagar to provide chemotherapy to oncology patients outside the hospital first standalone immigration center at Lajpat Nagar New Delhi the Responder-on-Bike initiative Max Centre for Liver and Biliary Sciences and oncology dedicated wing in Max Hospital Shalimar Bagh.In 2017 Max Super Speciality Hospital Shalimar Bagh introduced advanced silent MRI and intraoperative and portable CT scanner with navigation it became the first hospital in the network to get accredited by the Joint Commission International (JCI).The Company incorporated MHC Global Healthcare (Nigeria) Limited (MGHL) in Lagos Nigeria as a wholly owned subsidiary onMay 20 2019.The Hon'ble National Company Law Tribunal Mumbai Bench (NCLT) vide its order dated January 17 2020 sanctioned the Composite Scheme of Amalgamation and Arrangement amongst erstwhile Max India Limited the Company Radiant Max India Ltd. (formerly known as Advaita Allied Health Services Limited) and their respective shareholders and creditors and the Scheme was effective from June 1 2020. Subsequent to the effective date healthcare business of Radiant was demerged into the Company and also residual erstwhile Max India Ltd. (i.e. post demerger of allied health and associated services into Advaita Allied Health Services Limited) which comprises of healthcare activities amalgamated with the Company. Post demerger and amalgamation the Company became the second largest healthcare delivery chain in India (considering only income from healthcare services aggregated for Company Radiant and Partner Healthcare Facilities). Further pursuant to the Scheme equity shares of the Company were listed on the BSE Limited and National Stock Exchange of India Limited (NSE) on August 21 2020.As on March 31 2021 the Company has 6 subsidiaries.The current Promoters of the Company are Mr. Analjit Singh Ms. Neelu Analjit Singh Ms. Piya Singh Mr. Veer Singh Ms. Tara Singh Vachani MVIHPL Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. Pursuant to Scheme Analjit Singh Group is to be reclassified as public shareholders in accordance with the provisions of the Listing Regulations (such reclassification the Depromoterisation). Such Depromoterisation will be undertaken only upon the Company achieving the MPS requirement as prescribed under the SCRR. Post such Depromoterisation Mr. Abhay Soi and Kayak shall be the Promoters of the Company.During the year 2022 the Company acquired 26% stake in Eqova Healthcare Private Limited to expand its network footprint in East Delhi with addition of 400 beds on February 10 2022. It also entered into a long term exclusive Operation and Management Agreement with Muthoot Hospitals Private Limited for an upcoming hospital at Dwarka New Delhi on January 20 2022. On October 4 2021 the Company purchased two parcels of land admeasuring ~ 5.26 acres and ~ 6.11 acres in Gurugram Haryana on freehold basis for setting up two hospitals and expand the bed capacity of the Company in NCR region by ~1000 beds.Kayak Investments Holding Pte. Limited one of the Promoters of the Company sold 2726754 equity shares and consequent to the open market sale it complied with the MPS norms within the prescribed timelines i.e. with effect from August 20 2021. As a result at the end of FY 21-22 the public shareholding in the Company stood at 49.36%.Pursuant to Composite Scheme of Amalgamation and Arrangement amongst erstwhile Max India Limited the Company Radiant Life Care Private Limited Max India Limited (formerly known as Advaita Allied Health Services Limited) and their respective shareholders and creditors effective from June 1 2020 certain persons / entity belonging to Promoter / Promoter Group of the Company i.e. Max Ventures Investment Holdings Private Limited Mr. Analjit Singh Ms. Piya Singh Ms. Neelu Analjit Singh Ms. Tara Singh Vachani and Mr. Veer Singh have been re-classified as Public Category with the approval accorded by stock exchanges viz. BSE Limited and National Stock Exchange of India Limited (NSE) vide their letters dated March 24 2022. Therefore 406229 equity shares of the Companyheld by the above Promoter/ Promoter Group in aggregate representing 0.04% of its total issued and paid up capital at that time have been re-classified into `Public' from `Promoters / Promoter Group' category with effect from March 24 2022. Subsequent to re-classification of Promoter / Promoter Group the Company has only 2 Promoters i.e. Mr. Abhay Soi and Kayak.The Company commissioned 92-bedded Oncology Block at Max Super Speciality Hospital in Shalimar Bagh in March 2023. In 2023 a cloud deployment was undertaken for two key locations including Max Lajpat Nagar and Max Panchsheel. During FY23 Max@Home with the vision of `Digital First' launched Instant Doctor Consultation service.

Max Healthcare Institute Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 10
Latest Dividend (%)10.00
Latest Dividend Date 08 Sep 2023
Dividend Yield (%) 0.13
Book Value Share (₹) [S]74.65
P/B Ratio (₹) [S]10.32
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Canara Robeco Equity Hybrid Fund (IDCW-M) 108.36 1254000 1.11
Canara Robeco Equity Hybrid Fund (G) 108.36 1254000 1.11
Canara Robeco Equity Hybrid Fund - Direct (IDCW-M) 108.36 1254000 1.11
Canara Robeco Equity Hybrid Fund - Direct (G) 108.36 1254000 1.11
Canara Robeco Conservative Hybrid Fund (IDCW-M) 2.16 25000 0.22
Canara Robeco Conservative Hybrid Fund (G) 2.16 25000 0.22
Canara Robeco Conservative Hybrid Fund (IDCW-Q) 2.16 25000 0.22
Canara Robeco Conservative Hybrid Fund-Dir(IDCW-M) 2.16 25000 0.22
Canara Robeco Conservative Hybrid Fund-Dir(IDCW-Q) 2.16 25000 0.22
Canara Robeco Conservative Hybrid Fund-Dir (G) 2.16 25000 0.22

Load more

Research Reports

Date BrokerActionPrices(Rs)Report
08-05-2023Motilal Oswal Buy 430
11-04-2023Motilal Oswal Buy 430
07-02-2023Prabhudas Lilladher Buy 436

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week-9.35%-9.57%0.910.75%
1 Month0.54%0.52%2.392.40%
3 Month18.15%18.09%9.3710.41%
6 Month33.92%33.99%12.8815.14%
1 Year79.13%79.40%25.2929.19%
3 Year309.00%307.70%46.7450.00%

Company Info

Company Information

Chairman / Executive Director : Abhay Soi

Non-Exec & Non-Independent Dir : Anil Bhatnagar

Independent Non Exe. Director : K Narasimha Murthy

Independent Non Exe. Director : Mahendra Lodha

Independent Non Exe. Director : Michael Thomas Neeb

Independent Non Exe. Director : Pranav Amin

Independent Non Exe. Director : Amrita Gangotra

Non Executive Director : Narayan Seshadri

Registered Office: 167 Floor-1 Plot-167, Ready Money Mansion Worli,Mumbai,Maharashtra-400018 Ph: 91-22-66604447/48/49